DiagnosTear Technologies, Inc. (DTR) Stock Statistics & Valuation Metrics

DiagnosTear Technologies, Inc. has a market cap or net worth of CAD 15.16M. The enterprise value is CAD 19.11M.

Market Cap

CAD 15.16M

Enterprise Value

CAD 19.11M

DiagnosTear Technologies, Inc. has 60,638,336 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

60,638,336

Owned by Insiders

―

Owned by Institutions

―

DiagnosTear Technologies, Inc.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

―

Employee Count

0

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, DiagnosTear Technologies, Inc. had revenue of ― and earned -260.00K in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-260.00K

Pretax Income

―

Net Income

-260.00K

EBITDA

-260.00K

Earnings Per Share (EPS)

―

Beta

-0.48

52-Week Price Change

-52.83%

50-Day Moving Average

0.27

200-Day Moving Average

0.34

Relative Strength Index (RSI)

48.59

Average Volume (3m)

4,105

DiagnosTear Technologies, Inc. upcoming earnings date is Nov 24, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 28, 2026

Next Earnings Date

Nov 24, 2026

Ex-Dividend Date

―

DiagnosTear Technologies, Inc. has ― in cash and marketable securities with CAD 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

CAD 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for DiagnosTear Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

0

Revenue Growth Forecast

―

EPS Growth Forecast

―